Accordingly, the combination of exogenous melatonin treatment, transplantation of pineal gland, and stimulation of MT1 receptor in stem cells, together with other available stroke therapeutics (tPA), may prove advantageous in abrogating brain damage and behavioral deficits associated with stroke (Figure 1). This evidence concerns the gene PLAT and Stroke.